Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shattuck Labs, Inc.

Clinical trials sponsored by Shattuck Labs, Inc., explained in plain language.

Shattuck Labs, Inc. STTK NASDAQ

A clinical-stage biotech developing immunotherapies for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet recruiting 1 Not yet finished but already full! 1 Completed 1 Terminated 1

Can a new drug calm the Gut's overactive immune response in Crohn's?

Disease control Not yet recruiting

This phase 2 trial is testing whether an investigational drug called SL-325 can help adults with moderate to severe Crohn's disease. The study will compare SL-325 against a placebo to see if it reduces gut inflammation and improves symptoms. Participants will receive the treatmen…

Phase: PHASE2 • Sponsor: Shattuck Labs, Inc. • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC